Arthur Kavanaugh Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2020	Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study.
1/2018	Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arthur Kavanaugh Research Topics

Disease

106	Psoriatic Arthritis 02/2024 - 04/2005
94	Rheumatoid Arthritis 03/2024 - 02/2002
43	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 04/2005
24	Pain (Aches) 03/2024 - 02/2004
24	Arthritis (Polyarthritis) 02/2024 - 04/2005
18	Necrosis 02/2024 - 10/2003
17	Ankylosing Spondylitis 09/2022 - 07/2006
16	Inflammation (Inflammations) 03/2024 - 07/2008
14	Fatigue 12/2022 - 02/2004
14	Infections 01/2022 - 05/2004
9	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 10/2005
7	Joint Diseases (Joint Disease) 02/2024 - 09/2013
6	Neoplasms (Cancer) 01/2022 - 07/2008
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 10/2002
6	Disease Progression 09/2019 - 03/2006
5	Tuberculosis (Tuberculoses) 01/2022 - 05/2004
5	Chronic Disease (Chronic Diseases) 01/2021 - 12/2015
5	Rheumatic Diseases (Rheumatism) 01/2018 - 02/2006
4	Synovitis 03/2024 - 02/2011
4	Spondylitis 08/2023 - 12/2008
4	Crohn Disease (Crohn's Disease) 01/2023 - 11/2007
4	Skin Diseases (Skin Disease) 12/2022 - 01/2008
4	Gout 01/2017 - 03/2006
3	Opportunistic Infections (Opportunistic Infection) 01/2022 - 03/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 08/2020 - 09/2015
3	Nasopharyngitis 08/2020 - 09/2015
2	Axial Spondyloarthritis 08/2023 - 01/2023
2	Ulcerative Colitis 01/2023 - 01/2018
2	Nail Diseases (Nail Disease) 01/2022 - 04/2009
2	Headache (Headaches) 08/2020 - 10/2016
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Candidiasis (Moniliasis) 01/2020 - 01/2018
2	Lymphoma (Lymphomas) 11/2017 - 03/2015

Drug/Important Bio-Agent (IBA)

32	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 10/2002
29	Adalimumab (Humira)FDA Link 03/2024 - 07/2006
22	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 05/2004
22	golimumab FDA Link 01/2022 - 04/2009
20	Antirheumatic Agents (DMARD)IBA 02/2024 - 10/2003
18	C-Reactive ProteinIBA 03/2024 - 02/2011
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020 - 06/2002
14	ametantrone (HAQ)IBA 02/2024 - 02/2004
14	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 02/2009
11	apremilastIBA 01/2022 - 01/2014
10	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2007
10	Infliximab (Remicade)FDA Link 08/2013 - 06/2002
9	Interleukin-17 (Interleukin 17)IBA 02/2024 - 02/2014
9	Monoclonal AntibodiesIBA 12/2022 - 02/2009
9	secukinumabIBA 01/2022 - 09/2015
8	Etanercept (Enbrel)FDA Link 01/2023 - 07/2006
8	tofacitinibIBA 01/2022 - 01/2014
7	LipidsIBA 03/2024 - 10/2002
7	Rituximab (Mabthera)FDA Link 01/2016 - 09/2003
6	guselkumabIBA 02/2024 - 01/2021
6	InterleukinsIBA 02/2024 - 02/2009
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2003
6	Interleukin-12 (IL 12)IBA 01/2023 - 02/2009
6	CytokinesIBA 01/2023 - 02/2002
6	Certolizumab Pegol FDA Link 01/2020 - 01/2009
6	Interleukin-6 (Interleukin 6)IBA 10/2016 - 01/2003
5	Syk KinaseIBA 12/2014 - 11/2008
4	OxylipinsIBA 03/2024 - 01/2021
4	GLPG0634IBA 03/2024 - 01/2018
4	ixekizumabIBA 02/2024 - 07/2019
4	Prostaglandins AIBA 12/2023 - 09/2009
4	AntibodiesIBA 08/2022 - 03/2014
4	AntigensIBA 01/2020 - 03/2003
4	fostamatinibIBA 12/2014 - 02/2011
4	GlucocorticoidsIBA 10/2014 - 10/2003
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2023 - 01/2020
3	Interleukin-23 (Interleukin 23)IBA 12/2022 - 06/2014
3	Janus Kinase InhibitorsIBA 01/2022 - 12/2018
3	Rheumatoid FactorIBA 12/2021 - 05/2007
3	AutoantibodiesIBA 01/2018 - 02/2006
3	Phosphodiesterase 4 InhibitorsIBA 01/2018 - 06/2014
3	Uric Acid (Urate)IBA 01/2016 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2004
3	Immunoglobulins (Immunoglobulin)IBA 10/2010 - 12/2007
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2006 - 09/2003
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024 - 01/2021
2	upadacitinibIBA 01/2023 - 08/2022
2	bimekizumabIBA 12/2022 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2021
2	Anti-Citrullinated Protein AntibodiesIBA 12/2021 - 01/2008
2	cyclic citrullinated peptideIBA 12/2021 - 01/2008
2	Leflunomide (Arava)FDA LinkGeneric 06/2020 - 08/2004
2	Antiphospholipid AntibodiesIBA 01/2020 - 01/2020
2	amsonic acid (DAS)IBA 05/2019 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2018
2	GP2015IBA 01/2019 - 01/2018
2	EpitopesIBA 01/2018 - 11/2009
2	SteroidsIBA 01/2018 - 02/2011

Therapy/Procedure

74	Therapeutics 03/2024 - 02/2002
8	Biological Therapy 01/2018 - 07/2007
3	Subcutaneous Injections 01/2020 - 04/2009
2	Contraception (Birth Control) 01/2020 - 01/2020
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020 - 01/2020
2	Excimer Lasers 09/2019 - 01/2012
2	Aftercare (After-Treatment) 11/2018 - 10/2016